A carcinoid tumor associated with chylous ascites and elevated tumor markers.
The case is reported of a 74-year-old woman with a carcinoid tumor associated with chylous ascites and elevated tumor markers, CEA, and CA-125. In addition, the novel use of chromogranin-A quantitative assay from peripheral blood and ascetic fluid is discussed. The patient's clinical course and beneficial response to chemotherapy is also discussed and previous similar cases reported in the English-language literature are reviewed.
Warner
Richard R P
RR
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. warner_md@carcinoid.org
Croen
Edward C
EC
Zaveri
Kiran
K
Ratner
Lynn
L
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D002915:Chylous Ascites / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D010535:Laparoscopy; D010052:Ovariectomy / Q000379:methods; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen